Cellectar Biosciences, Inc. - CLRB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$1.071M
QoQ value delta ($000)
+$34K (+3.28%)
Implied price effect (QoQ)
-10.41%
Shares
Total shares
399,840
QoQ shares delta
+53,002 (+15.28%)
Total shares held by funds (by quarter)

Market chart (CLRB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 19 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 262 89,120 0.0%
Bleichroeder LP 254 100,000 0.04%
VANGUARD CAPITAL MANAGEMENT LLC 207 81,884 0.0%
GEODE CAPITAL MANAGEMENT, LLC 134 52,778 0.0%
Riverview Capital Advisers, LLC 50 10,384 0.02%
Sequoia Financial Advisors, LLC 47 18,850 0.0%
VANGUARD FIDUCIARY TRUST CO 42 16,573 0.0%
Warberg Asset Management LLC 35 13,900 0.01%
UBS Group AG 24 9,647 0.0%
BlackRock, Inc. 12 4,745 0.0%
Tower Research Capital LLC (TRC) 2 793 0.0%
MORGAN STANLEY 1 510 0.0%
Vanguard Global Advisers, LLC 1 563 0.0%
US BANCORP \DE\ 0 3 0.0%
DANSKE BANK A/S 0 2 0.0%
JONES FINANCIAL COMPANIES LLLP 0 3 0.0%
OSAIC HOLDINGS, INC. 0 1 0.0%
SBI Securities Co., Ltd. 0 11 0.0%
TD Waterhouse Canada Inc. 0 63 0.0%
FMR LLC 0 10 0.0%